Pneumonia is a bacterial infection that is a major cause of mortality worldwide [1, 2]. Importantly, even with improvements in treatment, diagnostics, and prevention, pneumonia remains a public health concern. Globally, pneumonia accounts for 16% of deaths annually among children younger than 5 years [3], but can progress to severe disease in all age groups. The mortality rate due to pneumonia is increasing annually in Korea [4]. In 2016, the number of deaths attributable to pneumonia in Korea increased by 11% compared to the previous year (from 28.9% in 2015 to 32.2%) [4]. The pathogens that cause most bacterial pneumonia infections are Bordetella pertussis (BP), Chlamydophila pneumoniae (CP), Haemophilus influenzae (HI), Legionella pneumophila (LP), Mycoplasma pneumoniae (MP), and Streptococcus pneumoniae (SP). These infections predominantly affect people who are very young, old, or immunocompromised. Pertussis, also known as whooping cough, is caused by BP and is one of the most severe respiratory infections [5]. A severe complication of pertussis is pneumonia, which has high rates of morbidity and mortality especially in infants younger than 6 months [6, 7]. HI is a common causative agent of pediatric pneumonia, with 43.8 cases per 100,000 per year of HI-induced pneumonia in Wales, UK [8]. LP accounts for approximately 10% to 20% of atypical pneumonia cases in Europe and the US but is relatively rare in Korea.